|
Myeloid Neoplasia
Citations 101-110 of 176 total displayed.
|
Past content
(since Jan 2009):
|
Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital
- Jeffrey E. Rubnitz, Mihaela Onciu, Stanley Pounds, Sheila Shurtleff, Xueyuan Cao, Susana C. Raimondi, Frederick G. Behm, Dario Campana, Bassem I. Razzouk, Raul C. Ribeiro, James R. Downing, and Ching-Hon Pui
Blood 2009; 113: 5083-5089.
[Abstract]
[Full text]
[PDF]
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication
- Aline Renneville, Nicolas Boissel, Nathalie Gachard, Dina Naguib, Christian Bastard, Stéphane de Botton, Olivier Nibourel, Cécile Pautas, Oumedaly Reman, Xavier Thomas, Claude Gardin, Christine Terré, Sylvie Castaigne, Claude Preudhomme, and Hervé Dombret
Blood 2009; 113: 5090-5093.
[Abstract]
[Full text]
[PDF]
The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome
- Selcuk Sozer, Maria Isabel Fiel, Thomas Schiano, Mingjiang Xu, John Mascarenhas, and Ronald Hoffman
Blood 2009; 113: 5246-5249.
[Abstract]
[Full text]
[PDF]
NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS)
- Friederike Schneider, Eva Hoster, Michael Unterhalt, Stephanie Schneider, Annika Dufour, Tobias Benthaus, Gudrun Mellert, Evelin Zellmeier, Stefan K. Bohlander, Michaela Feuring-Buske, Christian Buske, Jan Braess, Susanne Fritsch, Achim Heinecke, Maria C. Sauerland, Wolfgang E. Berdel, Thomas Buechner, Bernhard J. Woermann, Wolfgang Hiddemann, and Karsten Spiekermann
Blood 2009; 113: 5250-5253.
[Abstract]
[Full text]
[PDF]
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference
- Giovanni Barosi, Gunnar Birgegard, Guido Finazzi, Martin Griesshammer, Claire Harrison, Hans Carl Hasselbalch, Jean-Jacques Kiladjian, Eva Lengfelder, Mary Frances McMullin, Francesco Passamonti, John T. Reilly, Alessandro M. Vannucchi, and Tiziano Barbui
Blood 2009; 113: 4829-4833.
[Abstract]
[Full text]
[PDF]
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide
- Judith E. Karp, Karen Flatten, Eric J. Feldman, Jacqueline M. Greer, David A. Loegering, Rebecca M. Ricklis, Lawrence E. Morris, Ellen Ritchie, B. Douglas Smith, Valerie Ironside, Timothy Talbott, Gail Roboz, Son B. Le, Xue Wei Meng, Paula A. Schneider, Nga T. Dai, Alex A. Adjei, Steven D. Gore, Mark J. Levis, John J. Wright, Elizabeth Garrett-Mayer, and Scott H. Kaufmann
Blood 2009; 113: 4841-4852.
[Abstract]
[Full text]
[PDF]
Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities
- Sarah J. Horton, Vanessa Walf-Vorderwülbecke, Steve J. Chatters, Neil J. Sebire, Jasper de Boer, and Owen Williams
Blood 2009; 113: 4922-4929.
[Abstract]
[Full text]
[PDF]
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study
- Michele Baccarani, Gianantonio Rosti, Fausto Castagnetti, Ibrahim Haznedaroglu, Kimmo Porkka, Elisabetta Abruzzese, Giuliana Alimena, Hans Ehrencrona, Henrik Hjorth-Hansen, Veli Kairisto, Luciano Levato, Giovanni Martinelli, Arnon Nagler, Johan Lanng Nielsen, Ugur Ozbek, Francesca Palandri, Fausto Palmieri, Fabrizio Pane, Giovanna Rege-Cambrin, Domenico Russo, Giorgina Specchia, Nicoletta Testoni, Ole Weiss-Bjerrum, Giuseppe Saglio, and Bengt Simonsson
Blood 2009; 113: 4497-4504.
[Abstract]
[Full text]
[PDF]
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group
- Verena Ingeborg Gaidzik, Richard Friedrich Schlenk, Simone Moschny, Annegret Becker, Lars Bullinger, Andrea Corbacioglu, Jürgen Krauter, Brigitte Schlegelberger, Arnold Ganser, Hartmut Döhner, and Konstanze Döhner, for the German-Austrian AML Study Group
Blood 2009; 113: 4505-4511.
[Abstract]
[Full text]
[PDF]
Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells
- Sabine Mumprecht, Christina Claus, Christian Schürch, Viktor Pavelic, Matthias S. Matter, and Adrian F. Ochsenbein
Blood 2009; 113: 4681-4689.
[Abstract]
[Full text]
[PDF]
|
|
